BARACLUDE (Tablet, Film Coated)

Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/1695

Statements in which the resource exists.
SubjectPredicateObjectContext
dailymed-drugs:1695rdf:typehttp://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:1695rdf:typedailymed-instance:drugslld:dailymed
dailymed-drugs:1695rdfs:labelBARACLUDE (Tablet, Film Coated)lld:dailymed
dailymed-drugs:1695dailymed-instance:activeIng...dailymed-ingredient:entecav...lld:dailymed
dailymed-drugs:1695dailymed-instance:genericDr...http://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:1695dailymed-instance:boxedWarn...WARNINGS: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY: Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy. If appropriate, initiation of anti-hepatitis B therapy may be warranted [see Warnings and Precautions(5.1)]. Limited clinical experience suggests there is a potential for the development of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase inhibitors if BARACLUDE is used to treat chronic hepatitis B virus (HBV) infection in patients with HIV infection that is not being treated. Therapy with BARACLUDE is not recommended for HIV/HBV co-infected patients who are not also receiving highly active antiretroviral therapy (HAART) [see Warnings and Precautions(5.2)]. Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues alone or in combination with antiretrovirals [see Warnings and Precautions (5.3)].lld:dailymed
dailymed-drugs:1695dailymed-instance:activeMoi...dailymed-ingredient:entecav...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:magnesi...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:microcr...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:povidon...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:hyprome...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:titaniu...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:crospov...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:lactose...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:polyeth...lld:dailymed
dailymed-drugs:1695dailymed-instance:inactiveI...dailymed-ingredient:iron_ox...lld:dailymed
dailymed-drugs:1695dailymed-instance:possibleD...diseasome-diseases:1371lld:dailymed
dailymed-drugs:1695dailymed-instance:possibleD...diseasome-diseases:1372lld:dailymed
dailymed-drugs:1695dailymed-instance:possibleD...diseasome-diseases:1375lld:dailymed
dailymed-drugs:1695dailymed-instance:possibleD...diseasome-diseases:1637lld:dailymed
dailymed-drugs:1695dailymed-instance:genericMe...ENTECAVIRlld:dailymed
dailymed-drugs:1695dailymed-instance:fullNameBARACLUDE (Tablet, Film Coated)lld:dailymed
dailymed-drugs:1695dailymed-instance:represent...http://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:1695dailymed-instance:routeOfAd...http://www4.wiwiss.fu-berli...lld:dailymed
dailymed-drugs:1695dailymed-instance:nameBARACLUDElld:dailymed
http://www4.wiwiss.fu-berli...dailymed-instance:producesD...dailymed-drugs:1695lld:dailymed
diseasome-diseases:1371diseasome-instance:possible...dailymed-drugs:1695lld:diseasome
diseasome-diseases:1372diseasome-instance:possible...dailymed-drugs:1695lld:diseasome
diseasome-diseases:1375diseasome-instance:possible...dailymed-drugs:1695lld:diseasome
diseasome-diseases:1637diseasome-instance:possible...dailymed-drugs:1695lld:diseasome